Dr. Behr

Barry Behr, PhD, HCLD

La Jolla IVF Consulting Laboratory Director

Professor Stanford University
Obstetrics & Gynecology
Reproductive Endocrinology & Infertility

He is a nationally and internationally renowned clinical and scientific leader in the research and advances of human reproduction. As a world-renown scientist and lecturer, he is highly sought after to chair scientific programs and conferences, is the first non MD President of the Pacific Coast Reproductive Society and has been appointed as program chairman of several professional meetings. He is the co-director of the REI-IVF program at Stanford University and is the director of the Renew Biobank Institute for Stem Cell Biology and Regenerative Medicine and is in the forefront of clinical and scientific advances in reproduction, nationally and internationally.

Dr. Behr developed a culture medium for embryo culture to the blastocyst stage, which has improved pregnancy rates, implantation rates and reduced the risks of multiple gestation in IVF. Dr. Behr has been widely recognized for his research. He has published over 200 peer-reviewed publications and book chapters.


My desire is to understand and devise systems that would improve the experience for IVF patients.–Dr. Barry Behr, PhD, HCLD

 

Success Rates

La Jolla IVF is pleased to announce that from 1997 thru 2010 La Jolla IVF has provided care for over 1,500 Gestational Surrogate cases, over 1,200 Egg Donor cases and 800 Egg Donor / Gestational Surrogate cases.
Read More

Award-Winning Facility

”Our team of designers and medical professionals have spent a great deal of time and effort in making our offices and surgical facilities not only the most technically advanced, but also the most emotionally comforting. We couldn’t be more pleased to have this national recognition.”
- David B. Smotrich, M.D., F.A.C.O.G., Founder and Medical Director of
La Jolla IVF
Read More

Fertility Treatments

La Jolla IVF offers State-of-the-Art Treatment Plans for optimal outcomes. We also offer Customized Treatment Plans related to poor prognosis patients. It’s the clinics’s philosophy not to turn patients away.
Read More